Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
MEDIUM RISK
Score updated Aug 28, 2026

BMGL — Basel Medical Group Ltd Dilution Risk Tracker

Track BMGL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BMGL — Get alerts when the score changes →

As of August 28, 2026, Basel Medical Group Ltd (BMGL) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Basel Medical Group Ltd has a market capitalization of $11.16M, 18.79M shares outstanding, 5 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
62
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 55%
• 50-day avg $0.63 below $1 exchange minimum
🔔 Track BMGL — Get forecast alerts →

Market Data

Market Cap$11.16M
Shares Outstanding18.79M
Float6.02M
Cash$7.69M
Debt$5.11M
Short InterestN/A

Institutional Holdings

QoQ: ↓ 11.5% shares (2026Q1 vs prior)
5 institutional holders · 128.2K shares
#1 MORGAN STANLEY 74.3K shares
#2 XTX Topco Ltd 25.8K shares
#3 T3 Companies, LLC 15.0K shares
+ 2 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest15.7K
Days to Cover2.1
% of Float0.3%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track BMGL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BMGL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BMGL
BMGL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.